Deciphera Pharmaceuticals
Deciphera is seeking a seasoned Director of New Product Planning to steer the strategic direction of their clinical-stage pipeline. The role acts as the commercial voice within program teams, informing development and market strategies, and providing expert guidance to leadership on portfolio value and positioning. It involves collaboration across R&D, medical, and commercial functions to optimize asset development and commercialization plans.
Headquarters
Waltham, Massachusetts, United States
Company Size
201-500 employees
Founded
2003
Deciphera Pharmaceuticals, now a member of ONO Pharma, is a biopharmaceutical company dedicated to discovering, developing, and commercializing switch-control kinase inhibitors and other targeted therapies to improve outcomes for people with cancer. The company's portfolio includes approved medicines QINLOCK (ripretinib) for advanced gastrointestinal stromal tumor and ROMVIMZA (vimseltinib), as well as a broad pipeline of clinical-stage candidates such as tirabrutinib and sapablursen. Driven by a patient-inspired mission to defeat cancer, Deciphera focuses on addressing key mechanisms of tumor and drug resistance through its proprietary discovery platform.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Deciphera Pharmaceuticals.
51% above the average for this role
Product Research Specialist
Owens Corning
Product Planning Manager, Gaming Desktop
HP
Sr. Director, Product Marketing - XERF & Consumables
Cynosure Lutronic
Senior Global Marketing Director, Solid Tumor Oncology
GSK plc
Director, Pipeline Commercialization Strategy (PCS) - Prostate
AbbVie
VP, DM1 Commercial Asset Lead
Dyne Therapeutics